Merck & Co’s Keytruda shows potential in head and neck cancer useMerck & Co might be able to find another use for its immunotherapy Keytruda in first line head Share XMerck & Co’s Keytruda shows potential in head and neck cancer usehttps://pharmaphorum.com/news/keytruda-shows-promise-first-line-skin-cancer-treatment/
Novartis freezes drug prices in a nod to TrumpNovartis has announced it would not raise drug prices in the US this year, while Merck & Co Share XNovartis freezes drug prices in a nod to Trumphttps://pharmaphorum.com/news/novartis-freezes-drug-prices-in-a-nod-to-trump/
